Skip to content
DeepViews

Teleflex Incorporated (TFX) — Analysis Summary

Teleflex Incorporated (TFX) has a market cap of $5.52B with year-over-year revenue growth of -34.6%. Net margin stands at -45.4%. The stock trades at a P/E ratio of -5.4.

Key Takeaways

  • Revenue changed -34.6% year-over-year
  • Net margin of -45.4%
  • P/E ratio of -5.4

Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, TFX posted revenue growth of -34.6% and trades at a P/E of -5.4.

[XNYS]

Teleflex Incorporated (TFX)

$130.30

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$5521.12M
Enterprise Value
$8028.97M
P/E Ratio
-5.4
Div Yield
1.04%
EV/EBITDA
101.9
Company Profile
About
About Teleflex Incorporated

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.

Sector

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Employees

15,500

Headquarters

WAYNE, PA

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
48
Narrow Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$2904.53M
Total Debt$2808.01M
Debt-to-Equity0.97
Cash & Equivalents$300.16M

Cash Flow

Operating Cash Flow$154.06M
Free Cash Flow$90.63M
FCF Margin5.56%
P/FCF Ratio60.92
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$1.36

Dividend Yield

1.04%

Quarterly
Last Ex-Date: 2026-08-14

Dividend History

2026-08-14
CD$0.3400
2026-05-22
CD$0.3400
2026-03-06
CD$0.3400
2025-11-14
CD$0.3400
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.